Nombre del producto:4-(Aminomethyl)benzoic acid

IUPAC Name:4-(aminomethyl)benzoic acid

CAS:56-91-7
Fórmula molecular:C8H9NO2
Pureza:95%+
Número de catálogo:CM158174
Peso molecular:151.17

Unidad de embalaje Stock disponible Precio($) Cantidad
CM158174-1000g in stock ƩĜŁ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :56-91-7
Fórmula molecular:C8H9NO2
Punto de fusión:-
Código de sonrisas:C1=C(C=CC(=C1)CN)C(O)=O
Densidad:
Número de catálogo:CM158174
Peso molecular:151.17
Punto de ebullición:323.1°C at 760 mmHg
Nº Mdl:MFCD00010203
Almacenamiento:Protect from light and store in a dry and close container at 2°C~8°C

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Pirtobrutinib
Eli Lilly and Company announced that the U.S. FDA approved Jaypirca® (Pirtobrutinib) for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have received at least two prior lines of therapy, including a Bruton's tyrosine kinase (BTK) inhibitor and a BCL-2 inhibitor. Jaypirca (Pirtobrutinib) is a highly selective (300 times more selective for BTK versus 98% of other kinases tested in preclinical studies), non-covalent (reversible) inhibitor of the enzyme BTK.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.